Industry News

Marijuana Rated Significantly More Effective in Treating Fibromyalgia Symptoms than FDA-Approved Drugs, Global Survey Finds
Avion Pharmaceuticals, LLC, announces strategic alliance with Albion� Laboratories, Inc.
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C -Submission based on the largest Phase III program in genotype 1 (GT1) hepatitis C patients conducted to date(1)-Ab
Enanta Pharmaceuticals Announces New Drug Application Submission to the U.S. FDA for All-Oral, Interferon-Free Hepatitis C Regimen
COLDSTREAM LABORATORIES COMPLETES SUCCESSFUL FDA INSPECTION
Avion Pharmaceuticals announces strategic alliance with Albion Laboratories, Inc.
PinneyAssociates and DrugScan Collaborate to Offer In Vitro Tamper Testing of Abuse-Deterrent Drugs
Sagent Pharmaceuticals Announces the Reintroduction of Adenosine Injection, USP
Marijuana Rated Significantly More Effective in Treating Fibromyalgia Symptoms than FDA-Approved Drugs, Global Survey Finds
Aesica successfully introduces serialisation services at Italian finished dose manufacturing and packaging site
Sagent Pharmaceuticals Announces the Reintroduction of Adenosine Injection, USP
COLDSTREAM LABORATORIES COMPLETES SUCCESSFUL FDA INSPECTION
Emergent BioSolutions Receives Orphan Drug Designation for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease
Sarepta Therapeutics Announces Plans to Submit New Drug Application to FDA for Eteplirsen for the Treatment of Duchenne Muscular Dystrophy by Year End 2014
US pharmaceutical giant Pfizer keen to acquire AstraZeneaca for $100 billion
Emergent BioSolutions Closes BioThrax Clinical Study
Antares Pharma Secures Additional Patent Coverage for Otrexup
Boston Scientific Gets FDA Approval of New Defibrillators and Heart Failure Devices
DR REDDY'S LAUNCHES INSOMNIA DRUG IN US
J&J builds world's largest supply chain base
J&J builds world's largest supply chain base
MHRA -Two men sentenced for fake condom conspiracy
FDA official: Agency is committed to timely approval of vaccines
GLENMARK RECALLS RANITIDINE TABLETS
NanoValent and NanoSmart Enter Strategic Research Collaboration to Develop Enhanced Cancer Pharmaceuticals